Erythrocytes as carriers of metronidazole: In-vitro characterization
暂无分享,去创建一个
[1] M. Laguerre,et al. Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde. , 1989, Alcoholism, clinical and experimental research.
[2] S. Peters,et al. Effect of glutaraldehyde treatment on enzyme-loaded erythrocytes. , 1977, Biochimica et biophysica acta.
[3] V. Labhasetwar,et al. Nanoparticles - a colloidal drug delivery system for primaquine and metronidazole. , 1990 .
[4] E. Zocchi,et al. In vivo liver and lung targeting of adriamycin encapsulated in glutaraldehyde‐treated murine erythrocytes , 1988, Biotechnology and applied biochemistry.
[5] H. Alpar,et al. Therapeutic possibilities of drugs encapsulated in erythrocytes , 1984 .
[6] U. Zimmermann,et al. Enzyme loading of electrically homogeneous human red blood cell ghosts prepared by dielelctric breakdown. , 1976, Biochimica et biophysica acta.
[7] R. Michell,et al. Preparation of erythrocyte ghosts by a glycol-induced osmotic lysis under isoionic conditions. , 1976, Biochimica et biophysica acta.
[8] J. Deloach,et al. Circulating carrier erythrocytes: slow-release vehicle for an antileukemic drug, cytosine arabinoside. , 1982, American journal of veterinary research.
[9] N. Zöllner,et al. Osmotic fragility of drug carrier erythrocytes , 1985, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.